# RAD001, Cisplatin and Concurrent Radiation for Locally Advanced, Inoperable Head and Neck Cancer

> **NCT01057277** · PHASE1 · TERMINATED · sponsor: **howard safran** · enrollment: 3 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** RAD001(Afinitor)

## Key facts

- **NCT ID:** NCT01057277
- **Lead sponsor:** howard safran
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-12
- **Primary completion:** 2011-05
- **Final completion:** 2011-06
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Pharmaceutical co- re aligned their specialties- no longer will fund H\&N ca
- **Last updated:** 2020-02-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01057277

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01057277, "RAD001, Cisplatin and Concurrent Radiation for Locally Advanced, Inoperable Head and Neck Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01057277. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*